Clinical observation of dry needling therapy and local injection in the treatment of piriformis syndrome

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200063311

Enrollment

Unknown

Registered

2022-09-04

Start date

2022-09-20

Completion date

Unknown

Last updated

2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

piriformis syndrome

Interventions

one:dry needling

two:local injection

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ?Meet the diagnostic criteria for piriformis syndrome; ? Disease duration = 3 months; ? Age = 18 years old.

Exclusion criteria

Exclusion criteria: ? History of surgery in the hip area; ? lumbar nerve root compression, sacroiliitis; ? Any inflammatory, infectious or tumor-related pelvic and abdominal diseases; ? Those who are allergic to therapeutic drugs (lidocaine, paracetamol and tramadol) and those who have contraindications to glucocorticoids; ? Women who are menstruating, pregnant or breastfeeding; ? Suffering from serious blood system diseases or abnormal coagulation; ? Body mass index (BMI) less than 18.5 or greater than 28kg/m2.

Design outcomes

Primary

Measure	Time frame
Pain relief after therapeutic intervention;	—

Secondary

Measure	Time frame
hip range of motion;oswestry disability index;SF-36 Questionnaire;	—

Countries

China

Contacts

Public ContactYan Yuan

1046112@qq.com18052268635

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026